[Skip to Content]
[Skip to Content Landing]
Article
December 1987

In Vitro Killing of Melanoma by Liposome-Delivered Intracellular Irradiation

Author Affiliations

From the Department of Surgery, Division of Surgical Oncology, University of California, Davis Medical Center (Drs Pikul and Schneider), and the Laboratory of Energy-Related Health Research, University of California, Davis (Dr Parks). Dr Schneider is now with the University of Utah, Salt Lake City.

Arch Surg. 1987;122(12):1417-1420. doi:10.1001/archsurg.1987.01400240063011
Abstract

• To better understand and optimize the mechanism of alpha particle killing of tumors, an in vitro model utilizing liposomes as carrier vehicles was developed to study the killing of melanoma via intracellular α-irradiation. The radionuclide 212Pb (lead), with its 10.6-hour half-life and α-emitting daughter 212Bi (bismuth), was encapsulated in liposomes to achieve the intracellular irradiation of melanoma cells in culture. In dose-response experiments, B16F10 mouse melanoma cells were incubated with liposomes212Pb/212Bi bound to dextran 70. Plating efficiency and growth of the melanoma cells cultured on gridded petri dishes after incubation were compared with controls at 24 and 48 hours. Greater than 85% cell killing occurred by 48 hours, with administered radioactivity levels of 1.6 dpm/μmol of lipid/cell, which corresponds to intracellular delivery of five to seven alpha particles per cell. These alpha doses can be exceeded in vivo with recirculation or in a perfusion circuit, and more efficient cytotoxic action may be possible.

(Arch Surg 1987;122:1417-1420)

×